Lazio biotech sector fuels regional economic growth and competitiveness

The biotechnology and pharmaceutical industry in Italy's Lazio region is emerging as a leading industrial driver, complementing traditional sectors and boosting the area’s competitive profile. Anchored by research hubs such as the universities of Sapienza and Tor Vergata and a network of public and private institutes, the cluster supports advanced therapies, personalized medicine and AI applications in health.

Investment flows, integrated supply chains and high‑skill employment are expanding, with startups focusing on digital health, genomics and novel therapeutics. Industry leaders, including Bayer Italia, stress that continued innovation, manufacturing capacity and skilled personnel are essential to strengthen Italy’s overall competitiveness. Companies also cite the need for faster regulatory procedures and greater R&D funding to sustain international leadership and develop a recognizable territorial brand for life‑science excellence.

The sector now contributes significantly to regional exports and attracts both national and foreign capital, positioning Lazio among Europe’s most advanced health‑science areas.